Anticancer Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments
- AMR-1066254
- May 2021
- Pharmaceuticals
- 126 Pages
| Report Parameters | Details of Parameter |
| Market Size | xx Million |
| Based Year | 2020 |
| Forecast Period Covered | 2020 – 2028 |
| Units for value | Revenue in USD million and CAGR from 2020 to 2028 |
| Covered Segments | Component, Types, Applications, End-Users, and more. |
| Companies Covered | AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Celgene Corporation, F. Hoffmann-la Roche ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi |
| Region Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Anticancer Drugs market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Anticancer Drugs market is expected to attain Pre COVID-19 levels by mid-2022.
Anticancer Drugs Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.
Thereby at a glance a reader can understand all the factors and prospects of the Anticancer Drugs market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
Anticancer Drugs Market Competitive and Premeditated Analysis
In the Anticancer Drugs report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.
The readers and purchaser of the Anticancer Drugs research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
Major Key Players for Global Anticancer Drugs Market:
The Anticancer Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Celgene Corporation, F. Hoffmann-la Roche ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi
The Anticancer Drugs market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.
Anticancer Drugs Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.
The Global segmentation of the Anticancer Drugs market:
by Drug Type
Cytotoxic Drugs
Targeted Drugs
Hormonal Drugs
Therapy Type
Chemotherapy
Targeted Therapy
Immunotherapy
Cancer Type
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Regional Analysis of the Anticancer Drugs market:
The Anticancer Drugs market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.
By Regions:
- North America (U.S and Canada)
- Europe (U.K., Germany and France)
- Asia Pacific (China, India and Japan)
- Latin America (Mexico and Brazil)
- Middle East and Africa (GCC Countries and South Africa)
Major Factors Included and highlighted in the Anticancer Drugs report are as follows:
- The overall market value along with historic and future data analysis.
- The Growth drivers, opportunities and restraints are mention in detail.
- The size of the entire Anticancer Drugs market on a global perspective.
- The CAGR value of the overall market from 2020 to 2028.
- COVID-19 impact on the Anticancer Drugs market and how it is coping up with the situation.
- Major competitors and their contribution towards the market.
- The segmentation analysis is included which provides a clear picture of the market bifurcation.
- Tables and graphs that can easily been understood at a glance
- Latest trends and news related to the Anticancer Drugs market is included in the report.
The report aims to offer a complete solution to various businesses operating in the Anticancer Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anticancer Drugs market for numerous purposes such as:
1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.
2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anticancer Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anticancer Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.
3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anticancer Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.
Manufacturers and Segments
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- Celgene Corporation
- F. Hoffmann-la Roche ltd.
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Cytotoxic Drugs
- Targeted Drugs
- Hormonal Drugs
- Lung Cancer
- Breast Cancer
- Leukemia
- Colorectal Cancer
Have query on this report?
Make an Enquiry
1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
2. Executive Summarysegment Form
2.1. Global Anticancer Drugs Market Snapshot
2.1.1. Global Anticancer Drugs Market By Drug Type,2019
2.1.1.1.Cytotoxic Drugs
2.1.1.2.Targeted Drugs
2.1.1.3.Hormonal Drugs
2.1.2. Global Anticancer Drugs Market By Cancer Type,2019
2.1.2.1.Lung Cancer
2.1.2.2.Breast Cancer
2.1.2.3.Leukemia
2.1.2.4.Colorectal Cancer
2.1.3. Global Anticancer Drugs Market By End-use,2019
2.1.4. Global Anticancer Drugs Market By Geography,2019
3. Global Anticancer Drugs Market Dynamics
3.1. Market Overview
3.2. Market Inclination Insights Analysis
3.3. Drivers
3.4. Challenges
3.5. Future Prospects
3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)
4. Global Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
4.1. Overview
4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
4.1.2. Attractive Investment Proposition By Drug Type, 2020
4.2. Global Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
5. Global Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
5.1. Overview
5.1.1. Market Share Analysis By Cancer Type, 2019 vs.2028
5.1.2. Attractive Investment Proposition By Cancer Type, 2020
5.2. Global Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
6. Global Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
6.1. Overview
6.1.1. Market Share Analysis By End-use, 2019 vs.2028
6.1.2. Attractive Investment Proposition By End-use, 2020
6.2. Global Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7. Global Anticancer Drugs Market Size (US$), By Geography, 2018 – 2028
7.1. Overview
7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
7.1.2. Attractive Investment Proposition by Geography, 2020
7.2. North America Anticancer Drugs Market Analysis, 2018 – 2028
7.2.1. North America Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. North America Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.2.3. North America Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.2.4. North America Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.3. Europe Anticancer Drugs Market Analysis, 2018 – 2028
7.3.1. Europe Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.3.1.1. U.K.
7.3.1.2. Germany
7.3.1.3. France
7.3.1.4. Rest of Europe
7.3.2. Europe Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.3.3. Europe Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.3.4. Europe Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.4. Asia Pacific Anticancer Drugs Market Analysis , 2018 – 2028
7.4.1. Asia Pacific Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. Rest of Asia Pacific
7.4.2. Asia Pacific Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.4.3. Asia Pacific Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.4.4. Asia Pacific Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.5. Latin America Anticancer Drugs Market Analysis, 2018 – 2028
7.5.1. Latin America Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.5.3. Latin America Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.5.4. Latin America Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.6. Middle East & Africa (MEA) Anticancer Drugs Market Analysis, 2018 – 2028
7.6.1. MEA Anticancer Drugs Market Size (US$), By Region, 2018 – 2028
7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of MEA
7.6.2. MEA Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.6.3. MEA Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.6.4. MEA Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
8. Company Profiles
8.1. Competitive Analysis
8.2. Market Positioning of Key Vendors
8.3. Key Strategies adopted by the Leading Players
8.4. Key Anticancer Drugs Providers
8.4.1 AbbVie Inc.
8.4.1.1 Business Description
8.4.1.2 AbbVie Inc. Geographic Operations
8.4.1.3 AbbVie Inc. Financial Information
8.4.1.4 AbbVie Inc. Product Positions/Portfolio
8.4.1.5 AbbVie Inc. Key Developments
8.4.2 Astellas Pharma Inc.
8.4.2.1 Business Description
8.4.2.2 Astellas Pharma Inc. Geographic Operations
8.4.2.3 Astellas Pharma Inc. Financial Information
8.4.2.4 Astellas Pharma Inc. Product Positions/Portfolio
8.4.2.5 Astellas Pharma Inc. Key Developments
8.4.3 AstraZeneca PLC
8.4.3.1 Business Description
8.4.3.2 AstraZeneca PLC Geographic Operations
8.4.3.3 AstraZeneca PLC Financial Information
8.4.3.4 AstraZeneca PLC Product Positions/Portfolio
8.4.3.5 AstraZeneca PLC Key Developments
8.4.4 Celgene Corporation
8.4.4.1 Business Description
8.4.4.2 Celgene Corporation Geographic Operations
8.4.4.3 Celgene Corporation Financial Information
8.4.4.4 Celgene Corporation Product Positions/Portfolio
8.4.4.5 Celgene Corporation Key Developments
8.4.5 F. Hoffmann-la Roche ltd.
8.4.5.1 Business Description
8.4.5.2 F. Hoffmann-la Roche ltd. Geographic Operations
8.4.5.3 F. Hoffmann-la Roche ltd. Financial Information
8.4.5.4 F. Hoffmann-la Roche ltd. Product Positions/Portfolio
8.4.5.5 F. Hoffmann-la Roche ltd. Key Developments
8.4.6 Johnson & Johnson
8.4.6.1 Business Description
8.4.6.2 Johnson & Johnson Geographic Operations
8.4.6.3 Johnson & Johnson Financial Information
8.4.6.4 Johnson & Johnson Product Positions/Portfolio
8.4.6.5 Johnson & Johnson Key Developments
8.4.7 Merck & Co., Inc.
8.4.7.1 Business Description
8.4.7.2 Merck & Co., Inc. Geographic Operations
8.4.7.3 Merck & Co., Inc. Financial Information
8.4.7.4 Merck & Co., Inc. Product Positions/Portfolio
8.4.7.5 Merck & Co., Inc. Key Developments
8.4.8 Novartis AG
8.4.8.1 Business Description
8.4.8.2 Novartis AG Geographic Operations
8.4.8.3 Novartis AG Financial Information
8.4.8.4 Novartis AG Product Positions/Portfolio
8.4.8.5 Novartis AG Key Developments
8.4.9 Pfizer Inc.
8.4.9.1 Business Description
8.4.9.2 Pfizer Inc. Geographic Operations
8.4.9.3 Pfizer Inc. Financial Information
8.4.9.4 Pfizer Inc. Product Positions/Portfolio
8.4.9.5 Pfizer Inc. Key Developments
8.4.10 Sanofi
8.4.10.1 Business Description
8.4.10.2 Sanofi Geographic Operations
8.4.10.3 Sanofi Financial Information
8.4.10.4 Sanofi Product Positions/Portfolio
8.4.10.5 Sanofi Key Developments
LIST OF TABLES
TABLE 1 Market Snapshot: Global Anticancer Drugs Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 5 North America Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 6 North America Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 7 Europe Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 8 Europe Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 9 Europe Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 10 Asia Pacific Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 11 Asia Pacific Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 12 Asia Pacific Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 13 Latin America Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 14 Latin America Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 15 Latin America Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 17 MEA Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 18 MEA Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
LIST OF FIGURES
FIG. 1 Global Anticancer Drugs: Market Segmentation
FIG. 2 Global Anticancer Drugs Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Anticancer Drugs Market, By Drug Type, 2019 (US$ Mn)
FIG. 5 Global Anticancer Drugs Market, By Cancer Type, 2019 (US$ Mn)
FIG. 6 Global Anticancer Drugs Market, By End-use, 2019 (US$ Mn)
FIG. 7 Global Anticancer Drugs Market, By Geography, 2019 (US$ Mn)
FIG. 8 Global Anticancer Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Anticancer Drugs Providers, 2019
FIG. 11 Global Anticancer Drugs Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %)
FIG. 12 Global Anticancer Drugs Market Revenue Contribution, By Cancer Type, 2019 & 2028 (Value %)
FIG. 13 Global Anticancer Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %)
FIG. 14 North America Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 15 Europe Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 16 Asia Pacific Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 17 Latin America Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
Key Takeaways:
1. Market value and estimate of the Anticancer Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
2. Executive Summarysegment Form
2.1. Global Anticancer Drugs Market Snapshot
2.1.1. Global Anticancer Drugs Market By Drug Type,2019
2.1.1.1.Cytotoxic Drugs
2.1.1.2.Targeted Drugs
2.1.1.3.Hormonal Drugs
2.1.2. Global Anticancer Drugs Market By Cancer Type,2019
2.1.2.1.Lung Cancer
2.1.2.2.Breast Cancer
2.1.2.3.Leukemia
2.1.2.4.Colorectal Cancer
2.1.3. Global Anticancer Drugs Market By End-use,2019
2.1.4. Global Anticancer Drugs Market By Geography,2019
3. Global Anticancer Drugs Market Dynamics
3.1. Market Overview
3.2. Market Inclination Insights Analysis
3.3. Drivers
3.4. Challenges
3.5. Future Prospects
3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)
4. Global Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
4.1. Overview
4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
4.1.2. Attractive Investment Proposition By Drug Type, 2020
4.2. Global Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
5. Global Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
5.1. Overview
5.1.1. Market Share Analysis By Cancer Type, 2019 vs.2028
5.1.2. Attractive Investment Proposition By Cancer Type, 2020
5.2. Global Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
6. Global Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
6.1. Overview
6.1.1. Market Share Analysis By End-use, 2019 vs.2028
6.1.2. Attractive Investment Proposition By End-use, 2020
6.2. Global Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7. Global Anticancer Drugs Market Size (US$), By Geography, 2018 – 2028
7.1. Overview
7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
7.1.2. Attractive Investment Proposition by Geography, 2020
7.2. North America Anticancer Drugs Market Analysis, 2018 – 2028
7.2.1. North America Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. North America Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.2.3. North America Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.2.4. North America Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.3. Europe Anticancer Drugs Market Analysis, 2018 – 2028
7.3.1. Europe Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.3.1.1. U.K.
7.3.1.2. Germany
7.3.1.3. France
7.3.1.4. Rest of Europe
7.3.2. Europe Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.3.3. Europe Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.3.4. Europe Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.4. Asia Pacific Anticancer Drugs Market Analysis , 2018 – 2028
7.4.1. Asia Pacific Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. Rest of Asia Pacific
7.4.2. Asia Pacific Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.4.3. Asia Pacific Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.4.4. Asia Pacific Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.5. Latin America Anticancer Drugs Market Analysis, 2018 – 2028
7.5.1. Latin America Anticancer Drugs Market Size (US$), By Country, 2018 – 2028
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.5.3. Latin America Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.5.4. Latin America Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
7.6. Middle East & Africa (MEA) Anticancer Drugs Market Analysis, 2018 – 2028
7.6.1. MEA Anticancer Drugs Market Size (US$), By Region, 2018 – 2028
7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of MEA
7.6.2. MEA Anticancer Drugs Market Size (US$), By Drug Type, 2018 – 2028
7.6.3. MEA Anticancer Drugs Market Size (US$), By Cancer Type, 2018 – 2028
7.6.4. MEA Anticancer Drugs Market Size (US$), By End-use, 2018 – 2028
8. Company Profiles
8.1. Competitive Analysis
8.2. Market Positioning of Key Vendors
8.3. Key Strategies adopted by the Leading Players
8.4. Key Anticancer Drugs Providers
8.4.1 AbbVie Inc.
8.4.1.1 Business Description
8.4.1.2 AbbVie Inc. Geographic Operations
8.4.1.3 AbbVie Inc. Financial Information
8.4.1.4 AbbVie Inc. Product Positions/Portfolio
8.4.1.5 AbbVie Inc. Key Developments
8.4.2 Astellas Pharma Inc.
8.4.2.1 Business Description
8.4.2.2 Astellas Pharma Inc. Geographic Operations
8.4.2.3 Astellas Pharma Inc. Financial Information
8.4.2.4 Astellas Pharma Inc. Product Positions/Portfolio
8.4.2.5 Astellas Pharma Inc. Key Developments
8.4.3 AstraZeneca PLC
8.4.3.1 Business Description
8.4.3.2 AstraZeneca PLC Geographic Operations
8.4.3.3 AstraZeneca PLC Financial Information
8.4.3.4 AstraZeneca PLC Product Positions/Portfolio
8.4.3.5 AstraZeneca PLC Key Developments
8.4.4 Celgene Corporation
8.4.4.1 Business Description
8.4.4.2 Celgene Corporation Geographic Operations
8.4.4.3 Celgene Corporation Financial Information
8.4.4.4 Celgene Corporation Product Positions/Portfolio
8.4.4.5 Celgene Corporation Key Developments
8.4.5 F. Hoffmann-la Roche ltd.
8.4.5.1 Business Description
8.4.5.2 F. Hoffmann-la Roche ltd. Geographic Operations
8.4.5.3 F. Hoffmann-la Roche ltd. Financial Information
8.4.5.4 F. Hoffmann-la Roche ltd. Product Positions/Portfolio
8.4.5.5 F. Hoffmann-la Roche ltd. Key Developments
8.4.6 Johnson & Johnson
8.4.6.1 Business Description
8.4.6.2 Johnson & Johnson Geographic Operations
8.4.6.3 Johnson & Johnson Financial Information
8.4.6.4 Johnson & Johnson Product Positions/Portfolio
8.4.6.5 Johnson & Johnson Key Developments
8.4.7 Merck & Co., Inc.
8.4.7.1 Business Description
8.4.7.2 Merck & Co., Inc. Geographic Operations
8.4.7.3 Merck & Co., Inc. Financial Information
8.4.7.4 Merck & Co., Inc. Product Positions/Portfolio
8.4.7.5 Merck & Co., Inc. Key Developments
8.4.8 Novartis AG
8.4.8.1 Business Description
8.4.8.2 Novartis AG Geographic Operations
8.4.8.3 Novartis AG Financial Information
8.4.8.4 Novartis AG Product Positions/Portfolio
8.4.8.5 Novartis AG Key Developments
8.4.9 Pfizer Inc.
8.4.9.1 Business Description
8.4.9.2 Pfizer Inc. Geographic Operations
8.4.9.3 Pfizer Inc. Financial Information
8.4.9.4 Pfizer Inc. Product Positions/Portfolio
8.4.9.5 Pfizer Inc. Key Developments
8.4.10 Sanofi
8.4.10.1 Business Description
8.4.10.2 Sanofi Geographic Operations
8.4.10.3 Sanofi Financial Information
8.4.10.4 Sanofi Product Positions/Portfolio
8.4.10.5 Sanofi Key Developments
LIST OF TABLES
TABLE 1 Market Snapshot: Global Anticancer Drugs Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 5 North America Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 6 North America Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 7 Europe Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 8 Europe Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 9 Europe Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 10 Asia Pacific Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 11 Asia Pacific Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 12 Asia Pacific Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 13 Latin America Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 14 Latin America Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 15 Latin America Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anticancer Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn)
TABLE 17 MEA Anticancer Drugs Market Revenue, By Cancer Type, 2018 – 2028 (US$ Mn)
TABLE 18 MEA Anticancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
LIST OF FIGURES
FIG. 1 Global Anticancer Drugs: Market Segmentation
FIG. 2 Global Anticancer Drugs Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Anticancer Drugs Market, By Drug Type, 2019 (US$ Mn)
FIG. 5 Global Anticancer Drugs Market, By Cancer Type, 2019 (US$ Mn)
FIG. 6 Global Anticancer Drugs Market, By End-use, 2019 (US$ Mn)
FIG. 7 Global Anticancer Drugs Market, By Geography, 2019 (US$ Mn)
FIG. 8 Global Anticancer Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Anticancer Drugs Providers, 2019
FIG. 11 Global Anticancer Drugs Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %)
FIG. 12 Global Anticancer Drugs Market Revenue Contribution, By Cancer Type, 2019 & 2028 (Value %)
FIG. 13 Global Anticancer Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %)
FIG. 14 North America Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 15 Europe Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 16 Asia Pacific Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 17 Latin America Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anticancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
Key Takeaways:
1. Market value and estimate of the Anticancer Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage
List of Tables
TABLE Market Snapshot: Global Anticancer Drugs MarketTABLE Impact Pointers
TABLE Impact Analysis of Drivers and Restraints
TABLE North America Anticancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE North America Anticancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE North America Anticancer Drugs Market Value, By Country, 2018 – 2028
TABLE Europe Anticancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE Europe Anticancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE Europe Anticancer Drugs Market Value, By Country, 2018 – 2028
TABLE Asia Pacific Anticancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE Asia Pacific Anticancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE Asia Pacific Anticancer Drugs Market Value, By Country, 2018 – 2028
TABLE Latin America Anticancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE Latin America Anticancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE Latin America Anticancer Drugs Market Value, By Country, 2018 – 2028
TABLE MEA Anticancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE MEA Anticancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE MEA Anticancer Drugs Market Value, By Country, 2018 – 2028
TABLE AbbVie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Astellas Pharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE AstraZeneca PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Celgene Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE F. Hoffmann-la Roche ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
List of Figures
FIG. Global Anticancer Drugs Market: Research MethodologyFIG. Top-Down and Bottom Up Approach
FIG. Global Anticancer Drugs Market, By Segment1, 2019 (US$ Mn)
FIG. Global Anticancer Drugs Market, By Segment2, 2019 (US$ Mn)
FIG. Global Anticancer Drugs Market, By Geography, 2019 (US$ Mn)
FIG. Global Anticancer Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. Attractive Investment Proposition
FIG. Market Positioning of Key Anticancer Drugs Providers, 2016
FIG. Global Anticancer Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG. Global Targeted Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Hormonal Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Anticancer Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG. Global Breast Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Leukemia Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Colorectal Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG. Global Market Value, 2018 – 2028, (US$ Mn)
FIG. U.S. Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Canada Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. UK Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Germany Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. France Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Europe Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. China Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Japan Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. India Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Asia Pacific Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Mexico Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Brazil Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of Latin America Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. GCC Countries Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. South Africa Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG. Rest of MEA Anticancer Drugs Market Value, 2018 – 2028, (US$ Mn)